Cargando…
SUN-164 Use of Metformin, Premixed Insulin, and Glucagon-Like Peptide-1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes Mellitus
Background: Large doses of basal insulin may do little to improve glycemic. Adding pre-prandial insulin increases the number of injections and complicates treatment. Simplifying medication regimen by decreasing injections may improve compliance and lead to improved Hemoglobin A1c (HbA1c). Traditiona...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553273/ http://dx.doi.org/10.1210/js.2019-SUN-164 |